MedTrace Logo

Digital Solutions for bEtter cAre

NCT07416513 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-02-18

No results posted yet for this study

Summary

The target population includes cancer patients, caregivers, family members, healthcare providers and mental health specialists, who will be the primary end-users of the Althea platform. For patients, survivors, caregivers, and family members, the sample variables include age, gender, type and stage of disease, and time since the first diagnosis. The healthcare professionals that will be involved in this study are those who attend to oncological patients, with sample variables such as age, gender, professional role, and prior experience and training in oncology or psycho-oncology.

Conditions

  • Cancer Diagnosis

Interventions

BEHAVIORAL

Patients, survivors, caregivers, family members and healthcare professionals

Focus group discussions (FGD) and completion of survey

Sponsors & Collaborators

  • European Union

    collaborator OTHER

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Gabriella Pravettoni, MD · European Institute of Oncology

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-14
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • France
  • Germany
  • Italy
  • Lithuania
  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07416513 on ClinicalTrials.gov